Advisory Committee on Interdisciplinary, Community-Based Linkages; Notice of Meeting, 81624-81625 [2010-32560]

Download as PDF 81624 Federal Register / Vol. 75, No. 248 / Tuesday, December 28, 2010 / Notices publishes abstracts of information collection requests under review by the Office of Management and Budget (OMB), in compliance with the Paperwork Reduction Act of 1995 (44 U.S.C. Chapter 35). To request a copy of the clearance requests submitted to OMB for review, e-mail paperwork@hrsa.gov or call the HRSA Reports Clearance Office on (301) 443– 1129. The following request has been submitted to the Office of Management and Budget for review under the Paperwork Reduction Act of 1995: Proposed Project: The National Health Service Corps (NHSC) Scholarship Program Application (OMB No. 0915– 0146)—[Revision] The National Health Service Corps (NHSC) Scholarship Program provides the NHSC with the health professionals it requires to carry out its mission of providing primary health care to populations residing in areas of greatest need. Under this program, health professions students are awarded scholarships in return for service in a federally designated Health Professional Shortage Area (HPSA). Students are supported who are well qualified to participate in the NHSC Scholarship Program and who want to assist the NHSC in its mission, both during and after their period of obligated service. The NHSC Scholarship Program forms are used to collect relevant information necessary to make award determinations. Scholars are selected for these competitive awards based on the information provided in the application, forms, and supporting documentation. Awards are made to applicants who demonstrate a high potential for providing quality primary health care Number of respondents Instrument Responses/ respondent services in HPSAs. The program forms include the following: The NHSC Scholarship Program Application, Academic and Non-Academic Evaluation Letters (formerly Letters of Recommendation), the Authorization to Release Information, the Verification of Acceptance/Good Standing Report, the Receipt of Exceptional Financial Need Scholarship, the Verification Regarding Disadvantaged Background and the Acceptance/Declination Form. Also included are the Data Collection Worksheet, which is completed by the schools of program participants, the Deferment Request Form, which is completed by program participants and the Six-Month Service Obligation Verification Form, which is completed by program participants and their sites. The annual estimate of burden for applicants is as follows: Total responses Hours per response Total burden hours NHSC Scholarship Program Application ............................. Evaluation Letters ................................................................ Authorization to Release Information .................................. Verification of Acceptance/Good Standing Report .............. Receipt of Exceptional Financial Need Scholarship ............ Verification Regarding Disadvantaged Background ............ Acceptance/Declination Form .............................................. 1,800 1,800 1,800 1,800 100 300 250 1 2 1 1 1 1 1 1,800 3,600 1,800 1,800 100 300 250 2.0 .50 .10 .25 .25 .25 .10 3,600 1,800 180 450 25 75 25 Total .............................................................................. ........................ ........................ 9,400 ........................ 6,155 Number of respondents Responses/ respondent The annual estimate of burden for participants/schools/sites is as follows: Instrument Total responses Hours per response Total burden hours Data Collection Worksheet .................................................. Deferment Request Form .................................................... Six-Month Service Obligation Verification Form .................. 400 60 700 1 1 2 400 60 1,400 1.0 .25 .50 400 15 700 Total .............................................................................. ........................ ........................ 1,860 ........................ 1,115 emcdonald on DSK2BSOYB1PROD with NOTICES Written comments and recommendations concerning the proposed information collection should be sent within 30 days of this notice to the OMB desk officer for HRSA, either by e-mail to OIRA_submission@omb.eop.gov or by fax to 202–395–6974. Please direct all correspondence to the ‘‘attention of the OMB desk officer for HRSA.’’ Dated: December 21, 2010. Robert Hendricks, Director, Division of Policy and Information Coordination. [FR Doc. 2010–32562 Filed 12–27–10; 8:45 am] BILLING CODE 4165–15–P VerDate Mar<15>2010 22:37 Dec 27, 2010 Jkt 223001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Service Administration Advisory Committee on Interdisciplinary, Community-Based Linkages; Notice of Meeting In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), notice is hereby given of the following meeting: Name: Advisory Committee on Interdisciplinary, Community-Based Linkages (ACICBL). Dates and Times: January 27, 2011, 8:30 a.m. to 5 p.m., EST. January 28, 2011, 8:30 a.m. to 4 p.m., EST. PO 00000 Frm 00065 Fmt 4703 Sfmt 4703 Place: Hilton Washington DC/ Rockville Executive Meeting Center, 1750 Rockville Pike, Rockville, MD 20852. Telephone: 301–468–1100. Status: The meeting will be open to the public. Purpose: The members of the ACICBL will advance the planning required to develop their 11th Annual Report for the Secretary of the Department of Health and Human Services (the Secretary) and Congress, using the working topic, Continuing Education, Professional Development and Lifelong Learning for the 21st Century Health Care Workforce. The meeting will provide the planning and writing subcommittees with the opportunity to review the urgent issues related to the E:\FR\FM\28DEN1.SGM 28DEN1 Federal Register / Vol. 75, No. 248 / Tuesday, December 28, 2010 / Notices training programs, identify resources that will address the gaps and further strengthen the outcomes from these efforts, examine testimony from the experts in the field, and offer recommendations for improvement of these training programs to the Secretary and the Congress. Agenda: The ACICBL agenda includes an overview of the Committee’s general business activities, an orientation for the eight newly appointed members, presentations by and dialogue with experts, and discussion sessions specific to the development of recommendations to be addressed in the 11th Annual ACICBL Report. Agenda items are subject to change as dictated by the priorities of the Committee. Requests to make oral comments or to provide written comments to the ACICBL should be sent to Dr. Joan Weiss, Designated Federal Official at the contact information below. Individuals who plan to attend the meeting and need special assistance should notify Dr. Weiss at least 10 days prior to the meeting, using the address and phone number below. Members of the public will have the opportunity to provide comments at the meeting. SUPPLEMENTARY INFORMATION: FOR FURTHER INFORMATION CONTACT: Anyone requesting additional details should contact Dr. Joan Weiss, Designated Federal Official within the Bureau of Health Professions, Health Resources and Services Administration. Dr. Weiss may be reached by one of the three following methods: (1) Via written request to: Dr. Joan Weiss, Designated Federal Official, Bureau of Health Professions, Health Resources and Services Administration, Parklawn Building, Room 9–36, 5600 Fishers Lane, Rockville, Maryland 20857; (2) via telephone at (301) 443–6950; or (3) via e-mail at jweiss@hrsa.gov. In the absence of Dr. Weiss, CAPT Norma J. Hatot, Senior Nurse Consultant, may be contacted via telephone at (301) 443– 2681 or by e-mail at nhatot@hrsa.gov. emcdonald on DSK2BSOYB1PROD with NOTICES Dated: December 21, 2010. Robert Hendricks, Director, Division of Policy and Information Coordination. [FR Doc. 2010–32560 Filed 12–27–10; 8:45 am] BILLING CODE 4165–15–P VerDate Mar<15>2010 22:37 Dec 27, 2010 Jkt 223001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Government-Owned Inventions; Availability for Licensing National Institutes of Health, Public Health Service, HHS. ACTION: Notice. AGENCY: The inventions listed below are owned by an agency of the U.S. Government and are available for licensing in the U.S. in accordance with 35 U.S.C. 207 to achieve expeditious commercialization of results of Federally-funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing. ADDRESSES: Licensing information and copies of the U.S. patent applications listed below may be obtained by writing to the indicated licensing contact at the Office of Technology Transfer, National Institutes of Health, 6011 Executive Boulevard, Suite 325, Rockville, Maryland 20852–3804; telephone: 301/ 496–7057; fax: 301/402–0220. A signed Confidential Disclosure Agreement will be required to receive copies of the patent applications. SUMMARY: Hesperetin Therapy for Metabolic Syndrome and Insulin Resistance Description of Technology: Hesperidin is a flavonoid compound found in citrus fruits. Large epidemiological studies have linked increased consumption of flavonoidrich foods, such as citrus, with reduced cardiovascular morbidity and mortality. Investigators from the National Center for Complementary and Alternative Medicine have demonstrated that administration of oral hesperidin to patients with metabolic syndrome attenuates biomarkers of inflammation and improves blood vessel relaxation, lipid cholesterol profiles, and insulin sensitivity when compared to controls. Thus, hesperidin and its active aglycone form, hesperetin, may be effective agents for the treatment of diabetes, obesity, metabolic syndrome, dyslipidemias, and their cardiovascular complications including hypertension, atherosclerosis, coronary heart disease, and stroke. This technology discloses methods for using a hesperetin composition to treat metabolic syndrome and insulin resistance. Applications: Therapeutics for metabolic syndrome and insulin resistance. PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 81625 Development Status: Clinical trial data available. Inventors: Michael J. Quon and Ranganath Muniyappa (NCCAM). Publications: Manuscript in preparation. Patent Status: U.S. Provisional Application No. 61/369,229 filled 30 July 2010 (HHS Reference No. E–148– 2010/0–US–01). Licensing Status: Available for licensing. Licensing Contact: Tara L. Kirby, Ph.D.; 301–435–4426; kirbyt@mail.nih.gov. Substituted Triazine and Purine Compounds for the Treatment of Chagas Disease and African Trypanosomiasis Description of Technology: Parasitic protozoa are responsible for a wide variety of infections in both humans and animals. Trypanosomiasis poses health risks to millions of people across multiple countries in Africa and North and South America. Visitors to these regions, such as business travelers and tourists, are also at risk for contracting parasitic diseases. There are two types of African trypanosomiasis, also known as sleeping sickness. One type is caused by the parasite Trypanosoma brucei gambiense, and the other is caused by the parasite Trypanosoma brucei rhodesiensi. If left untreated, African sleeping sickness results in death. Chagas disease, caused by Trypanosoma cruzi (T. cruzi), affects millions of people in Mexico and South and Central America. Untreated, Chagas disease causes decreased life expectancy and can also result in death. The subject invention covers novel triazine and purine compounds that are inhibitors of key proteases (cruzain and Rhodesian) of the parasites Trypanosoma brucei rhodesiensi and Trypanosoma cruzi, respectively. Applications: Prophylactic and therapeutic treatment of African trypanosomiasis and Chagas disease. Advantages • Novel compounds against the cysteine proteases, cruzain and rhodesain. • Compounds possess low nanomolar inhibitory potential against cruzain and rhodesain. Development Status: In vitro and in vivo data are available upon request and upon execution of an appropriate confidentiality agreement. Inventors: Craig J. Thomas et al. (NHGRI). Related Publication: BT Mott et al. Identification and optimization of inhibitors of Trypanosomal cysteine E:\FR\FM\28DEN1.SGM 28DEN1

Agencies

[Federal Register Volume 75, Number 248 (Tuesday, December 28, 2010)]
[Notices]
[Pages 81624-81625]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-32560]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Service Administration


Advisory Committee on Interdisciplinary, Community-Based 
Linkages; Notice of Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), notice is hereby given of the following 
meeting:
    Name: Advisory Committee on Interdisciplinary, Community-Based 
Linkages (ACICBL).
    Dates and Times: January 27, 2011, 8:30 a.m. to 5 p.m., EST. 
January 28, 2011, 8:30 a.m. to 4 p.m., EST.
    Place: Hilton Washington DC/Rockville Executive Meeting Center, 
1750 Rockville Pike, Rockville, MD 20852. Telephone: 301-468-1100.
    Status: The meeting will be open to the public.
    Purpose: The members of the ACICBL will advance the planning 
required to develop their 11th Annual Report for the Secretary of the 
Department of Health and Human Services (the Secretary) and Congress, 
using the working topic, Continuing Education, Professional Development 
and Lifelong Learning for the 21st Century Health Care Workforce. The 
meeting will provide the planning and writing sub-committees with the 
opportunity to review the urgent issues related to the

[[Page 81625]]

training programs, identify resources that will address the gaps and 
further strengthen the outcomes from these efforts, examine testimony 
from the experts in the field, and offer recommendations for 
improvement of these training programs to the Secretary and the 
Congress.
    Agenda: The ACICBL agenda includes an overview of the Committee's 
general business activities, an orientation for the eight newly 
appointed members, presentations by and dialogue with experts, and 
discussion sessions specific to the development of recommendations to 
be addressed in the 11th Annual ACICBL Report. Agenda items are subject 
to change as dictated by the priorities of the Committee.

SUPPLEMENTARY INFORMATION: Requests to make oral comments or to provide 
written comments to the ACICBL should be sent to Dr. Joan Weiss, 
Designated Federal Official at the contact information below. 
Individuals who plan to attend the meeting and need special assistance 
should notify Dr. Weiss at least 10 days prior to the meeting, using 
the address and phone number below. Members of the public will have the 
opportunity to provide comments at the meeting.

FOR FURTHER INFORMATION CONTACT: Anyone requesting additional details 
should contact Dr. Joan Weiss, Designated Federal Official within the 
Bureau of Health Professions, Health Resources and Services 
Administration. Dr. Weiss may be reached by one of the three following 
methods: (1) Via written request to: Dr. Joan Weiss, Designated Federal 
Official, Bureau of Health Professions, Health Resources and Services 
Administration, Parklawn Building, Room 9-36, 5600 Fishers Lane, 
Rockville, Maryland 20857; (2) via telephone at (301) 443-6950; or (3) 
via e-mail at jweiss@hrsa.gov. In the absence of Dr. Weiss, CAPT Norma 
J. Hatot, Senior Nurse Consultant, may be contacted via telephone at 
(301) 443-2681 or by e-mail at nhatot@hrsa.gov.

    Dated: December 21, 2010.
Robert Hendricks,
Director, Division of Policy and Information Coordination.
[FR Doc. 2010-32560 Filed 12-27-10; 8:45 am]
BILLING CODE 4165-15-P